SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is trending with immense community interest due to escalating geopolitical discussions surrounding the United States' strategic interest in acquiring Greenland, which hosts CRML's significant Tanbreez rare earth project. Investors are actively discussing the potential for government involvement to secure critical rare earth supplies, driving substantial trading volume and speculation about a significant price surge. This heightened conversation reflects a broader market focus on establishing Western independence in the crucial rare earth sector.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy (MSTR) is trending sharply higher after MSCI announced it will not exclude Digital Asset Treasury Companies from its global indexes, reversing earlier plans. The community is buzzing with excitement, anticipating a significant short squeeze and a "path back to normalcy" following previous delisting fears. This decision removes a major overhang, fueling discussions of a substantial rally despite some lingering caution regarding Bitcoin's volatility.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing an explosive rally driven by intense demand for memory and storage within the rapidly expanding AI infrastructure sector, with community discussion highlighting widespread memory shortages and the stock's parabolic ascent. This significant price surge and high trading volume have ignited active debate among investors regarding the sustainability of the 'AI supercycle' and its valuation.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending amidst anticipation surrounding its Northern Data acquisition, which is expected to expand its cloud and GPU capabilities, potentially securing government contracts. Major investor Tether is also committing substantial funds for advertising and cloud services, coinciding with high community chatter about a looming short squeeze driven by significant short interest and the upcoming Rumble Wallet with crypto payment options.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending due to significant volatility following analyst downgrades from competitor banks, which many in the community perceive as market manipulation designed to acquire shares at a lower price. This sentiment is fueled by the recent completion of a public offering where underwriters exercised options to buy shares. Despite the sharp dip, long-term investors are actively 'buying the dip,' anticipating strong upcoming earnings and potential S&P 500 inclusion.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as community discussions highlight a perceived liquidity shortage and its appeal as a faster, lower-fee alternative to Bitcoin during network congestion. Traders are closely watching key resistance levels, anticipating a significant price breakout driven by these factors and ongoing developments in interoperability.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy (IMSR) is seeing renewed market interest after executing an agreement with the U.S. Department of Energy for Project TETRA, aiming to advance its Integral Molten Salt Reactor (IMSR) plant development. This news has ignited community discussion comparing its potential to sector peers like OKLO, emphasizing its role in the advanced nuclear era and the growing demand for clean energy, especially for AI infrastructure.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is actively trending as investors eagerly await its upcoming earnings report, with community speculation high regarding accelerated AI infrastructure demand and potential for new hyperscaler contracts to drive significant growth. Despite some caution around a transitional quarter impacting headline earnings, the focus remains on long-term guidance, cash flow, and the company's position to capitalize on the crucial data center bottleneck for high-performance computing. The notable short interest is also fueling discussions of a potential squeeze, adding to the bullish sentiment.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc. is generating significant buzz following news of its innovative 3D-printed fuel tank technology and upcoming flight test, a development seen as a major step in advancing space transportation. The community is actively discussing the company's place within the burgeoning aerospace sector, with many anticipating substantial growth given its relatively small market valuation. High short interest and notable borrowing fees are also fueling expectations for increased price volatility.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending amidst heightened activity in the GLP-1 market, with upcoming J.P. Morgan conference participation and recent headlines about Novo Nordisk's oral Wegovy launching at aggressive pricing fueling community debate. Bulls strongly believe VKTX's VK2735, a dual GLP-1/GIP agonist with promising oral and injectable data, is significantly undervalued and poised for a major acquisition or substantial growth, while bears criticize management's perceived reluctance to secure a buyout and worry about escalating competition. The core tension centers on whether Viking can successfully navigate the rapidly evolving obesity and MASH landscape as an independent entity or if a strategic partnership or acquisition is inevitable, with the community actively discussing potential catalysts like regulatory feedback on oral VK2735's Phase 3 path.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioAge Labs (NASDAQ:BIOA) Hits New 12-Month High - Time to Buy?

BioAge Labs (NASDAQ:BIOA) Hits New 12-Month High - Here's Why...

BioAge Labs (NASDAQ:BIOA) Sets New 52-Week High - Still a Buy?

BioAge Labs (NASDAQ:BIOA) Sets New 12-Month High - Still a Buy...

Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors

Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors There are just nine days left in the year, and this year has flown by. We've delivered readers a steady stream of 2026...

Paul Rubin Sells 18,000 Shares of BioAge Labs (NASDAQ:BIOA) Stock

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 18,000 shares of the stock in a transaction that occurred on Tuesday, December 9th. The stock was sold at an average price of...

BioAge Labs (NASDAQ:BIOA) Insider Sells $216,000.00 in Stock

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 18,000 shares of the business's stock in a transaction that occurred on Tuesday, December 9th. The stock was sold at an...

Paul Rubin Sells 68,897 Shares of BioAge Labs (NASDAQ:BIOA) Stock

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 68,897 shares of the firm's stock in a transaction that occurred on Thursday, December 4th. The stock was sold at an average...

BioAge Labs (NASDAQ:BIOA) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded BioAge Labs from a "sell" rating to a "hold" rating in a report on Saturday...

Jefferies Financial Group Inc. Buys Shares of 50,000 BioAge Labs, Inc. $BIOA

Jefferies Financial Group Inc. bought a new stake in BioAge Labs, Inc. (NASDAQ:BIOA - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities...

BioAge Labs (NASDAQ:BIOA) Issues Quarterly Earnings Results

BioAge Labs (NASDAQ:BIOA - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.56) EPS for the quarter, beating analysts' consensus estimates of ($0.67) by...

BioAge Labs’ stock&nbsp;lost more than two-thirds of its market cap in pre-market trading Monday, poised to hit an all-time low following its decision to discontinue the STRIDES Phase 2 study of azelaprag, its investigational obesity drug.&nbsp;The halt, announced on Friday, came after some subjects in the azelaprag treatment arms showed elevated liver enzymes, though no clinically significant symptoms were reported.&nbsp;The tirzepatide-only treatment group did not exhibit transaminase elevations, according to the company.CEO Kristen Fortney said, "We made the difficult decision to discontinue the STRIDES Phase 2 study of azelaprag because it became clear that the emerging safety profile of the current doses tested is inconsistent with our goal of a best-in-class oral obesity therapy.”&nbsp;BioAge said it remains focused on developing therapies for metabolic aging and advancing its NLRP3 inhibitor program alongside other research initiatives.The news spurred swift Wall Street downgrades on Monday.&nbsp;Jefferies cut its rating from ‘Buy’ to ‘Hold’ and slashed its price target from $42 to $7, noting the unexpected liver signal after a clean safety profile in eight prior Phase 1 studies by BioAge and Amgen.&nbsp;Citi also downgraded the stock to ‘Neutral’ from ‘Buy’, reducing its price target from $45 to $7. The brokerage highlighted that the liver toxicity concerns significantly limit azelaprag’s potential in obesity treatments and eliminate a key catalyst for BioAge’s shares.<figure class="image"><a href="https://stocktwits.com/symbol/BIOA"><img style="aspect-ratio:1318/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_09_at_6_21_42_PM_bad10ec021.png" alt="Screenshot 2024-12-09 at 6.21.42 PM.png" width="1318" height="318"></a><figcaption>BIOA sentiment and message volume on Dec 9 premarket as of 7:45 am ET | source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits turned sharply ‘bearish’ after the announcement, a reversal from ‘bullish’ levels the previous day.&nbsp;Investors expressed frustration over the trial’s discontinuation and the steep decline in share value.<stembedurl>https://stocktwits.com/ProKnifeCatcher87/message/595559186</stembedurl><stembedurl>https://stocktwits.com/texmade2/message/595509540</stembedurl>BioAge, which had seen strong market interest since its IPO in September amid the weight-loss drug frenzy, is now down over 10% year-to-date.&nbsp;For updates and corrections email newsroom[at]stocktwits[dot]com.

Jefferies cut its rating on BioAge from ‘Buy’ to ‘Hold’ and slashed its price target from $42 to $7

BioAge Stock Nosedives On Obesity Drug Study Halt: Downgrades Crush Retail Sentiment

BioAge, which had seen strong market interest since its IPO in September amid the weight-loss drug frenzy, is now down over 10% year-to-date.

Equity

BioAge, which had seen strong market interest since its IPO in September amid the weight-loss drug frenzy, is now down over 10% year-to-date.


BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.

BioAge Labs Inc.

Physical AI Infrastructure

Power & Energy to Support Growth

Healthcare Value & Innovation

Other – Comment Below

As markets head into 2026, investors are debating whether the next phase favors speculation or real-world execution. With capital rotating toward infrastructure, energy, and undervalued sectors like healthcare, which area do you think will matter most for portfolios in the year ahead?

Which Theme Will Matter Most for Portfolios in 2026?

BIOA
BioAge Labs Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BIOA News

BIOABioAge Labs Inc.